services
Expertise in helping clients and their programs navigate the 505(b)(2) drug development pathway
Supporting 505(b)(2) programs from conceptualization, navigating Pre-IND conversations and meetings, and seamless execution of multi-country trials.
Product Concept Evaluation
- Candidate identification
- Feasibility assessment
- Assessing regulatory pathway
- Development and execution of clinical development plan
- Market access, securing code reimbursement and payment
Regulatory Support
- Pre IND, IND, NDA, and ANDA preparation
- Submission and Maintenance
Nonclinical strategy and study design, CRO identification & qualification, Project Management
Clinical Study Planning and execution
Orphan Drug Designation